What's Going On With Rockwell Medical (RMTI) Stock
Portfolio Pulse from Vandana Singh
Rockwell Medical Inc (RMTI) has acquired the hemodialysis concentrates business from Evoqua Water Technologies. The deal includes $11 million upfront in cash and two milestone payments of $2.5 million each. The acquisition will expand Rockwell's footprint in the U.S. and increase its market share in the hemodialysis concentrates market. Following the acquisition, Rockwell has increased its FY23 revenue guidance to $82 million-$86 million. Despite the positive news, RMTI shares are trading lower.
July 11, 2023 | 4:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Rockwell Medical's acquisition of Evoqua's hemodialysis concentrates business is expected to expand its market share and increase its FY23 revenue. However, RMTI shares are trading lower.
The acquisition is a strategic move for Rockwell Medical to expand its market share and increase its revenue. However, the market reaction to this news is negative, with RMTI shares trading lower. This could be due to various factors such as market sentiment, overall market conditions, or investor perception of the deal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100